A cost utility analysis of simeprevir used with peginterferon + ribavirin in the management of genotype 1 hepatitis C virus infection, from the perspective of the UK National Health Service

2015 ◽  
Vol 18 (10) ◽  
pp. 838-849 ◽  
Author(s):  
Kirsten Westerhout ◽  
Maarten Treur ◽  
Angelika Mehnert ◽  
Katie Pascoe ◽  
Imran Ladha ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
National Health Service ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Hepatitis C Virus Infection ◽  
Genotype 1 ◽  
Utility Analysis ◽  
Uk National Health Service ◽  
The Uk

Cost–utility analysis of ledipasvir/sofosbuvir for the treatment of genotype 1 chronic hepatitis C in Japan

2016 ◽  
Vol 33 (1) ◽  
pp. 11-21 ◽  
Author(s):  
Ataru Igarashi ◽  
Wentao Tang ◽  
Ines Guerra ◽  
Lucile Marié ◽  
Sandrine Cure ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Genotype 1 ◽  
Utility Analysis
Sign in / Sign up

Export Citation Format

Share Document